Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Brenda Sandmaier
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Living Beings
Chemicals & Drugs
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
107
Storb, Rainer
57
Maloney, David
52
Maris, Michael
43
Chauncey, Thomas
28
Appelbaum, Frederick
26
McSweeney, Peter
24
Sorror, Mohamed
24
Storer, Barry
22
Blume, Karl
22
Deeg, Joachim
20
Bruno, Benedetto
20
Storer, Barry
20
Shizuru, Judith
18
Niederwieser, Dietger
17
Schuening, Friedrich
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Brenda Sandmaier (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bacigalupo Andrea; Ballen Karen; Rizzo Doug; Giralt Sergio; Lazarus Hillard; Ho Vincent; Apperley Jane; Slavin Shimon; Pasquini Marcelo; Sandmaier Brenda M; Barrett John; Blaise Didier; Lowski Robert; Horowitz Mary
Defining the intensity of conditioning regimens: working definitions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1628-33.
-
2009: Gyurkocza Boglarka; Cao Thai M; Storb Rainer F; Lange Thoralf; Leisenring Wendy; Franke Georg N; Sorror Mohamed; Hoppe Richard; Maloney David G; Negrin Robert S; Shizuru Judith A; Sandmaier Brenda M
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1314-22.
-
2009: Ding Yunchuan; Rotta Marcello; Graves Scott S; Storer Barry E; Peterson Laura J; Sale George E; Forough Reza; Zellmer Eustacia; Georges George E; Sandmaier Brenda M; Kuhr Christian S; Storb Rainer
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1244-50.
-
2009: Thakar Monica S; Zhang Xiao-Bing; Beard Brian C; Sale George E; Santos Erlinda B; Peterson Laura; Kiem Hans-Peter; Sandmaier Brenda M
Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model.
Experimental hematology 2009;37(10):1157-66.
-
2009: Salinger David H; Blough David K; Vicini Paolo; Anasetti Claudio; O'Donnell Paul V; Sandmaier Brenda M; McCune Jeannine S
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5280-7.
-
2009: Nakamae Hirohisa; Kirby Katharine A; Sandmaier Brenda M; Norasetthada Lalita; Maloney David G; Maris Michael B; Davis Chris; Corey Lawrence; Storb Rainer; Boeckh Michael
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):694-703.
-
2009: Baron Frédéric; Petersdorf Effie W; Gooley Ted; Sandmaier Brenda M; Malkki Mari; Chauncey Thomas R; Maloney David G; Storb Rainer
What is the role for donor natural killer cells after nonmyeloablative conditioning?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):580-8.
-
2009: Rotta Marcello; Storer Barry E; Sahebi Firoozeh; Shizuru Judith A; Bruno Benedetto; Lange Thoralf; Agura Edward D; McSweeney Peter A; Pulsipher Michael A; Hari Parameswaran; Maziarz Richard T; Chauncey Thomas R; Appelbaum Frederick R; Sorror Mohamed L; Bensinger William; Sandmaier Brenda M; Storb Rainer F; Maloney David G
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
-
2009: Woodahl Erica L; Wang Joanne; Heimfeld Shelly; Sandmaier Brenda M; McCune Jeannine S
Intracellular disposition of fludarabine triphosphate in human natural killer cells.
Cancer chemotherapy and pharmacology 2009;63(5):959-64.
-
2009: Nakamae Hirohisa; Wilbur D Scott; Hamlin Donald K; Thakar Monica S; Santos Erlinda B; Fisher Darrell R; Kenoyer Aimee L; Pagel John M; Press Oliver W; Storb Rainer; Sandmaier Brenda M
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
Cancer research 2009;69(6):2408-15.
-
2008: Burroughs Lauri M; O'Donnell Paul V; Sandmaier Brenda M; Storer Barry E; Luznik Leo; Symons Heather J; Jones Richard J; Ambinder Richard F; Maris Michael B; Blume Karl G; Niederwieser Dietger W; Bruno Benedetto; Maziarz Richard T; Pulsipher Michael A; Petersen Finn B; Storb Rainer; Fuchs Ephraim J; Maloney David G
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1279-87.
-
2008: Rezvani Andrew R; Norasetthada Lalitha; Gooley Ted; Sorror Mohamed; Bouvier Michelle E; Sahebi Firoozeh; Agura Edward; Chauncey Thomas; Maziarz Richard T; Maris Michael; Shizuru Judith; Bruno Benedetto; Bredeson Christopher; Lange Thoralf; Yeager Andrew; Sandmaier Brenda M; Storb Rainer F; Maloney David G
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
British journal of haematology 2008;143(3):395-403.
-
2008: Sorror Mohamed L; Storer Barry E; Sandmaier Brenda M; Maris Michael; Shizuru Judith; Maziarz Richard; Agura Edward; Chauncey Thomas R; Pulsipher Michael A; McSweeney Peter A; Wade James C; Bruno Benedetto; Langston Amelia; Radich Jerald; Niederwieser Dietger; Blume Karl G; Storb Rainer; Maloney David G
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
-
2008: Tykodi Scott S; Fujii Nobuharu; Vigneron Nathalie; Lu Sharon M; Mito Jeffrey K; Miranda Maureen X; Chou Jeffrey; Voong Lilien N; Thompson John A; Sandmaier Brenda M; Cresswell Peter; Van den Eynde Benoît; Riddell Stanley R; Warren Edus H
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5260-9.
-
2008: Luznik Leo; O'Donnell Paul V; Symons Heather J; Chen Allen R; Leffell M Susan; Zahurak Marianna; Gooley Ted A; Piantadosi Steve; Kaup Michele; Ambinder Richard F; Huff Carol Ann; Matsui William; Bolaños-Meade Javier; Borrello Ivan; Powell Jonathan D; Harrington Elizabeth; Warnock Sandy; Flowers Mary; Brodsky Robert A; Sandmaier Brenda M; Storb Rainer F; Jones Richard J; Fuchs Ephraim J
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):641-50.
-
2008: Sorror Mohamed; Storer Barry; Sandmaier Brenda M; Maloney David G; Chauncey Thomas R; Langston Amelia; Maziarz Richard T; Pulsipher Michael; McSweeney Peter A; Storb Rainer
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 2008;112(9):1992-2001.
-
2008: Sala-Torra O; Martin P J; Storer B; Traina F; Sorror M L; Storb R; Sandmaier B M; Flowers M E D
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens.
Bone marrow transplantation 2008;41(10):887-93.
-
2008: Laport Ginna G; Sandmaier Brenda M; Storer Barry E; Scott Bart L; Stuart Monic J; Lange Thoralf; Maris Michael B; Agura Edward D; Chauncey Thomas R; Wong Ruby M; Forman Stephen J; Petersen Finn B; Wade James C; Epner Elliot; Bruno Benedetto; Bethge Wolfgang A; Curtin Peter T; Maloney David G; Blume Karl G; Storb Rainer F
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):246-55.
-
2008: Rezvani Andrew R; Storer Barry; Maris Michael; Sorror Mohamed L; Agura Edward; Maziarz Richard T; Wade James C; Chauncey Thomas; Forman Stephen J; Lange Thoralf; Shizuru Judith; Langston Amelia; Pulsipher Michael A; Sandmaier Brenda M; Storb Rainer; Maloney David G
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
-
2008: Sorror Mohamed L; Storer Barry E; Maloney David G; Sandmaier Brenda M; Martin Paul J; Storb Rainer
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
Blood 2008;111(1):446-52.
-
2007: Mielcarek Marco; Storer Barry E; Sandmaier Brenda M; Sorror Mohamed L; Maloney David G; Petersdorf Effie; Martin Paul J; Storb Rainer
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1499-507.
-
2007: Sorror Mohamed L; Giralt Sergio; Sandmaier Brenda M; De Lima Marcos; Shahjahan Munir; Maloney David G; Deeg H Joachim; Appelbaum Frederick R; Storer Barry; Storb Rainer
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
-
2007: Campregher P V; Gooley T; Scott B L; Moravec C; Sandmaier B; Martin P J; Deeg H J; Warren E H; Flowers M E D
Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation.
Bone marrow transplantation 2007;40(10):965-71.
-
2007: Mielcarek Marco; Storer Barry E; Flowers Mary E D; Storb Rainer; Sandmaier Brenda M; Martin Paul J
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1160-8.
-
2007: Kahl Christoph; Storer Barry E; Sandmaier Brenda M; Mielcarek Marco; Maris Michael B; Blume Karl G; Niederwieser Dietger; Chauncey Thomas R; Forman Stephen J; Agura Edward; Leis Jose F; Bruno Benedetto; Langston Amelia; Pulsipher Michael A; McSweeney Peter A; Wade James C; Epner Elliot; Bo Petersen Finn; Bethge Wolfgang A; Maloney David G; Storb Rainer
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2007;110(7):2744-8.
-
2007: Sorror Mohamed L; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Baron Frédéric; Maloney David G; Scott Bart L; Deeg H Joachim; Appelbaum Frederick R; Storb Rainer
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
-
2007: Baron Frédéric; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Langston Amelia A; Lange Thoralf; Petersdorf Effie; Bethge Wolfgang; Maziarz Richard T; McSweeney Peter A; Pulsipher Michael A; Wade James C; Chauncey Thomas R; Shizuru Judith A; Sorror Mohamed L; Woolfrey Ann E; Maloney David G; Storb Rainer
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
-
2007: Chang Chunkang; Storer Barry E; Scott Bart L; Bryant Eileen M; Shulman Howard M; Flowers Mary E; Sandmaier Brenda M; Witherspoon Robert P; Nash Richard A; Sanders Jean E; Bedalov Antonio; Hansen John A; Clurman Bruce E; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.
Blood 2007;110(4):1379-87.
-
2007: Giralt Sergio; Logan Brent; Rizzo Douglas; Zhang Mei-Jie; Ballen Karen; Emmanouilides Christos; Nath Rajneesh; Parker Pablo; Porter David; Sandmaier Brenda; Waller Edmund K; Barker Juliet; Pavletic Steven; Weisdorf Daniel
Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):844-52.
-
2007: Georges George E; Maris Michael B; Maloney David G; Sandmaier Brenda M; Sorror Mohamed L; Shizuru Judith A; Lange Thoralf; Agura Edward D; Bruno Benedetto; McSweeney Peter A; Pulsipher Michael A; Chauncey Thomas R; Mielcarek Marco; Storer Barry E; Storb Rainer
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):423-32.
-
2007: Kerbauy Daniella M B; Gooley Theodore A; Sale George E; Flowers Mary E D; Doney Kristine C; Georges George E; Greene Joanne E; Linenberger Michael; Petersdorf Effie; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed; Stirewalt Derek L; Stewart F Marc; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):355-65.
-
2007: Sandmaier Brenda M; Mackinnon Stephen; Childs Richard W
Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1 Suppl 1):87-97.
-
2006: Baron Frédéric; Storer Barry; Maris Michael B; Storek Jan; Piette Fanny; Metcalf Monja; White Kristen; Sandmaier Brenda M; Maloney David G; Storb Rainer; Boeckh Michael
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1176-87.
-
2006: Baron F; Sandmaier B M
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(10):1690-700.
-
2006: Baron Frédéric; Storb Rainer; Storer Barry E; Maris Michael B; Niederwieser Dietger; Shizuru Judith A; Chauncey Thomas R; Bruno Benedetto; Forman Stephen J; McSweeney Peter A; Maziarz Richard T; Pulsipher Michael A; Agura Edward D; Wade James; Sorror Mohamed; Maloney David G; Sandmaier Brenda M
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
-
2006: Fukuda Takahiro; Kerbauy Fabio R; Gooley Theodore; Santos Erlinda B; Storb Rainer; Sandmaier Brenda M
Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
Transplantation 2006;82(3):332-9.
-
2006: Baron Frédéric; Sandmaier Brenda M; Zellmer Eustacia; Sorror Mohamed; Storer Barry; Storb Rainer
Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):813-7.
-
2006: Bethge Wolfgang A; Wilbur D Scott; Sandmaier Brenda M
Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.
Leukemia & lymphoma 2006;47(7):1205-14.
-
2006: Gopal Ajay K; Pagel John M; Rajendran Joseph G; Maloney David G; Appelbaum Frederick R; Sorror Mohamed L; Sandmaier Brenda M; Storb Rainer; Press Oliver W
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):697-702.
-
2006: Deeg H Joachim; Storer Barry E; Boeckh Michael; Martin Paul J; McCune Jeannine S; Myerson David; Heimfeld Shelly; Flowers Mary E; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Nash Richard A; O'Donnell Paul V; Radich Jerald P; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed L; Warren E Houston; Witherspoon Robert P; Woolfrey Ann; Appelbaum Frederick R; Storb Rainer
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
-
2006: Maris Michael B; Sandmaier Brenda M; Storer Barry E; Maloney David G; Shizuru Judith A; Agura Edward; Kliem Constanze; Pulsipher Michael; Maziarz Richard T; McSweeney Peter A; Wade James; Langston Amelia A; Chauncey Thomas R; Bruno Benedetto; Blume Karl G; Storb Rainer
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):454-65.
-
2006: Burroughs Lauri; Mielcarek Marco; Leisenring Wendy; Sandmaier Brenda M; Maloney David G; Baron Frédéric; Martin Paul J; Flowers Mary E D; Forman Stephen J; Chauncey Thomas R; Bruno Benedetto; Storb Rainer
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 2006;81(6):818-25.
-
2006: Hegenbart Ute; Niederwieser Dietger; Sandmaier Brenda M; Maris Michael B; Shizuru Judith A; Greinix Hildegard; Cordonnier Catherine; Rio Bernard; Gratwohl Alois; Lange Thoralf; Al-Ali Haifa; Storer Barry; Maloney David; McSweeney Peter; Chauncey Thomas; Agura Ed; Bruno Benedetto; Maziarz Richard T; Petersen Finn; Storb Rainer
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):444-53.
-
2006: Scott B L; Sandmaier B M; Storer B; Maris M B; Sorror M L; Maloney D G; Chauncey T R; Storb R; Deeg H J
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):128-35.
-
2006: Scott Bart L; Sandmaier Brenda M
Outcomes with myeloid malignancies.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2006;():381-9.
-
2005: Giaccone Luisa; McCune Jeannine S; Maris Michael B; Gooley Theodore A; Sandmaier Brenda M; Slattery John T; Cole Scott; Nash Richard A; Storb Rainer F; Georges George E
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.
Blood 2005;106(13):4381-8.
-
2005: Burroughs Lauri; Mielcarek Marco; Little Marie-Térèse; Bridger Gary; Macfarland Ron; Fricker Simon; Labrecque Jean; Sandmaier Brenda M; Storb Rainer
Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.
Blood 2005;106(12):4002-8.
-
2005: Panse Jens P; Storb Rainer; Storer Barry; Santos Erlinda B; Wentzel Collette; Sandmaier Brenda M
Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation.
Transplantation 2005;80(10):1518-21.
-
2005: Griffith Linda M; Pavletic Steven Z; Tyndall Alan; Bredeson Christopher N; Bowen James D; Childs Richard W; Gratwohl Alois; van Laar Jacob M; Mayes Maureen D; Martin Roland; McSweeney Peter A; Muraro Paolo A; Openshaw Harry; Saccardi Riccardo; Sandmaier Brenda M; Forman Stephen J; Nash Richard A;
Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(11):862-70.
-
2005: Baron Frédéric; Sandmaier Brenda M
Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning.
Current opinion in hematology 2005;12(6):435-43.
-
2005: Sorror Mohamed L; Maris Michael B; Storb Rainer; Baron Frederic; Sandmaier Brenda M; Maloney David G; Storer Barry
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Blood 2005;106(8):2912-9.
-
2005: Bethge Wolfgang A; Sandmaier Brenda M
Targeted cancer therapy using radiolabeled monoclonal antibodies.
Technology in cancer research & treatment 2005;4(4):393-405.
-
2005: Sorror Mohamed L; Maris Michael B; Sandmaier Brenda M; Storer Barry E; Stuart Monic J; Hegenbart Ute; Agura Edward; Chauncey Thomas R; Leis Jose; Pulsipher Michael; McSweeney Peter; Radich Jerald P; Bredeson Christopher; Bruno Benedetto; Langston Amelia; Loken Michael R; Al-Ali Haifa; Blume Karl G; Storb Rainer; Maloney David G
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3819-29.
-
2005: Kerbauy F R; Storb R; Hegenbart U; Gooley T; Shizuru J; Al-Ali H K; Radich J P; Maloney D G; Agura E; Bruno B; Epner E M; Chauncey T R; Blume K G; Niederwieser D; Sandmaier B M
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):990-7.
-
2005: Mielcarek Marco; Burroughs Lauri; Leisenring Wendy; Diaconescu Razvan; Martin Paul J; Sandmaier Brenda M; Maloney David G; Maris Michael B; Chauncey Thomas R; Shizuru Judith A; Blume Karl G; Hegenbart Ute; Niederwieser Dietger; Forman Stephen; Bruno Benedetto; Woolfrey Ann; Storb Rainer
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 2005;129(3):381-91.
-
2005: Baron F; Maris M B; Storer B E; Sandmaier B M; Panse J P; Chauncey T R; Sorror M; Little M-T; Maloney D G; Storb R; Heimfeld S
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(5):822-8.
-
2005: Chien Jason W; Maris Michael B; Sandmaier Brenda M; Maloney David G; Storb Rainer F; Clark Joan G
Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):288-96.
-
2005: Baron Frédéric; Maris Michael B; Storer Barry E; Sandmaier Brenda M; Stuart Monic J; McSweeney Peter A; Radich Jerald P; Pulsipher Michael A; Agura Edward D; Chauncey Thomas R; Maloney David G; Shizuru Judith A; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):272-9.
-
2005: Baron Frédéric; Maris Michael B; Sandmaier Brenda M; Storer Barry E; Sorror Mohamed; Diaconescu Razvan; Woolfrey Ann E; Chauncey Thomas R; Flowers Mary E D; Mielcarek Marco; Maloney David G; Storb Rainer
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1993-2003.
-
2005: Parikh Chirag R; Schrier Robert W; Storer Barry; Diaconescu Razvan; Sorror Mohamed L; Maris Michael B; Maloney David G; McSweeney Peter; Storb Rainer; Sandmaier Brenda M
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(3):502-9.
-
2005: Panse J P; Heimfeld S; Guthrie K A; Maris M B; Maloney D G; Baril B B; Little M-T; Chauncey T R; Storer B E; Storb R; Sandmaier B M
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
British journal of haematology 2005;128(5):659-67.
-
2005: Flowers M E D; Traina F; Storer B; Maris M; Bethge W A; Carpenter P; Appelbaum F; Storb R; Sandmaier B M; Martin P J
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning.
Bone marrow transplantation 2005;35(3):277-82.
-
2004: Holmberg Leona A; Sandmaier Brenda M
Vaccination with Theratope (STn-KLH) as treatment for breast cancer.
Expert review of vaccines 2004;3(6):655-63.
-
2004: Tykodi Scott S; Warren Edus H; Thompson John A; Riddell Stanley R; Childs Richard W; Otterud Brith E; Leppert Mark F; Storb Rainer; Sandmaier Brenda M
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7799-811.
-
2004: Maris Michael B; Sandmaier Brenda M; Storer Barry E; Chauncey Thomas; Stuart Monic Jain; Maziarz Richard T; Agura Edward; Langston Amelia A; Pulsipher Michael; Storb Rainer; Maloney David G
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood 2004;104(12):3535-42.
-
2004: Baron Frédéric; Baker Jennifer E; Storb Rainer; Gooley Theodore A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Heimfeld Shelly; Oparin Dmitrij; Zellmer Eustacia; Radich Jerald P; Grumet F Carl; Blume Karl G; Chauncey Thomas R; Little Marie-Térèse
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2004;104(8):2254-62.
-
2004: Diaconescu Razvan; Flowers Christopher R; Storer Barry; Sorror Mohamed L; Maris Michael B; Maloney David G; Sandmaier Brenda M; Storb Rainer
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Blood 2004;104(5):1550-8.
-
2004: Bethge Wolfgang A; Wilbur D Scott; Storb Rainer; Hamlin Donald K; Santos Erlinda B; Brechbiel Martin W; Sandmaier Brenda M
Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study.
Transplantation 2004;78(3):352-9.
-
2004: Sorror Mohamed L; Maris Michael B; Storer Barry; Sandmaier Brenda M; Diaconescu Razvan; Flowers Christopher; Maloney David G; Storb Rainer
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Blood 2004;104(4):961-8.
-
2004: Parikh Chirag R; Sandmaier Brenda M; Storb Rainer F; Blume Karl G; Sahebi Firoozeh; Maloney David G; Maris Michael B; Nieto Yago; Edelstein Charles L; Schrier Robert W; McSweeney Peter
Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
Journal of the American Society of Nephrology : JASN 2004;15(7):1868-76.
-
2004: Fukuda Takahiro; Boeckh Michael; Guthrie Katherine A; Mattson Debra K; Owens Stephanie; Wald Anna; Sandmaier Brenda M; Corey Lawrence; Storb Rainer F; Marr Kieren A
Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(7):494-503.
-
2004: Holmberg Leona A; Sandmaier Brenda
Vaccination as a treatment for breast or ovarian cancer.
Expert review of vaccines 2004;3(3):269-77.
-
2004: Bethge Wolfgang A; Sandmaier Brenda M
Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies.
Seminars in oncology 2004;31(1):68-82.
-
2004: Bethge Wolfgang A; Hegenbart Ute; Stuart Monic J; Storer Barry E; Maris Michael B; Flowers Mary E D; Maloney David G; Chauncey Thomas; Bruno Benedetto; Agura Ed; Forman Stephen J; Blume Karl G; Niederwieser Dietger; Storb Rainer; Sandmaier Brenda M
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Blood 2004;103(3):790-5.
-
2004: Hogan William J; Maris Michael; Storer Barry; Sandmaier Brenda M; Maloney David G; Schoch H Gary; Woolfrey Ann E; Shulman Howard M; Storb Rainer; McDonald George B
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.
Blood 2004;103(1):78-84.
-
2003: Deeg H Joachim; Gooley Theodore A; Flowers Mary E D; Sale George E; Slattery John T; Anasetti Claudio; Chauncey Thomas R; Doney Kristine; Georges George E; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie W; Radich Jerald; Sanders Jean E; Sandmaier Brenda M; Warren E Houston; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
-
2003: Junghanss Christian; Storb Rainer; Maris Michael B; Carter Rachel A; Sandmaier Brenda M; Maloney David G; McSweeney Peter A; Corey Lawrence; Boeckh Michael
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 2003;123(4):662-70.
-
2003: Maloney David G; Molina Arthur J; Sahebi Firoozeh; Stockerl-Goldstein Keith E; Sandmaier Brenda M; Bensinger William; Storer Barry; Hegenbart Ute; Somlo George; Chauncey Thomas; Bruno Benedetto; Appelbaum Frederick R; Blume Karl G; Forman Stephen J; McSweeney Peter; Storb Rainer
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
-
2003: Bethge Wolfgang A; Storer Barry E; Maris Michael B; Flowers Mary E D; Maloney David G; Chauncey Thomas R; Woolfrey Ann E; Storb Rainer; Sandmaier Brenda M
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.
Experimental hematology 2003;31(10):974-80.
-
2003: Maris Michael; Boeckh Michael; Storer Barry; Dawson Monja; White Kristen; Keng Michael; Sandmaier Brenda; Maloney David; Storb Rainer; Storek Jan
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning.
Experimental hematology 2003;31(10):941-52.
-
2003: Fukuda Takahiro; Hackman Robert C; Guthrie Katherine A; Sandmaier Brenda M; Boeckh Michael; Maris Michael B; Maloney David G; Deeg H Joachim; Martin Paul J; Storb Rainer F; Madtes David K
Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation.
Blood 2003;102(8):2777-85.
-
2003: Maris Michael B; Niederwieser Dietger; Sandmaier Brenda M; Storer Barry; Stuart Monic; Maloney David; Petersdorf Effie; McSweeney Peter; Pulsipher Michael; Woolfrey Ann; Chauncey Thomas; Agura Ed; Heimfeld Shelly; Slattery John; Hegenbart Ute; Anasetti Claudio; Blume Karl; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
Blood 2003;102(6):2021-30.
-
2003: Panse Jens P; Bastianelli Carla; Santos Erlinda B; Schwarzinger Ilse; Raff Robert F; Storb Rainer; Sandmaier Brenda M
Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cells.
Transplantation 2003;76(3):474-80.
-
2003: Fukuda Takahiro; Boeckh Michael; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Martin Paul J; Storb Rainer F; Marr Kieren A
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Blood 2003;102(3):827-33.
-
2003: Kurre Peter; Pulsipher Michael; Woolfrey Ann; Maris Michael; Sandmaier Brenda; Kiem Hans-Peter; Storb Rainier
Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donor.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(7):581-3.
-
2003: Mielcarek Marco; Martin Paul J; Leisenring Wendy; Flowers Mary E D; Maloney David G; Sandmaier Brenda M; Maris Michael B; Storb Rainer
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Blood 2003;102(2):756-62.
-
2003: Bethge Wolfgang A; Wilbur D Scott; Storb Rainer; Hamlin Donald K; Santos Erlinda B; Brechbiel Martin W; Fisher Darrell R; Sandmaier Brenda M
Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.
Blood 2003;101(12):5068-75.
-
2003: Feinstein Lyle C; Sandmaier Brenda M; Maloney David G; Maris Michael B; Gooley Theodore A; Chauncey Thomas R; Hegenbart Ute; McSweeney Peter A; Stuart Monic J; Forman Stephen J; Agura Edward A; Pulsipher Michael A; Blume Karl G; Niederwieser Dietger W; Storb Rainer F
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(4):266-72.
-
2003: Holmberg Leona A; Oparin Dimitri V; Gooley Ted; Sandmaier Brenda M
The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope).
Clinical breast cancer 2003;3 Suppl 4():S144-51.
-
2003: Sandmaier Brenda M; Fukuda Takahiro; Gooley Theodore; Yu Cong; Santos Erlinda B; Storb Rainer
Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.
Experimental hematology 2003;31(2):168-75.
-
2003: Niederwieser Dietger; Maris Michael; Shizuru Judith A; Petersdorf Effie; Hegenbart Ute; Sandmaier Brenda M; Maloney David G; Storer Barry; Lange Thoralf; Chauncey Thomas; Deininger Michael; Pönisch Wolfram; Anasetti Claudio; Woolfrey Ann; Little Marie-Terese; Blume Karl G; McSweeney Peter A; Storb Rainer F
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
Blood 2003;101(4):1620-9.
-
2003: Feinstein Lyle C; Sandmaier Brenda M; Hegenbart Ute; McSweeney Peter A; Maloney David G; Gooley Theodore A; Maris Michael B; Chauncey Thomas R; Bruno Benedetto; Appelbaum Frederick R; Niederwieser Dietger W; Storb Rainer F
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 2003;120(2):281-8.
-
2002: Maciej Zaucha J; Mielcarek Marco; Takatu Alessandra; Little Marie-Terese; Gooley Theodore; Baker Jennifer; Maloney David G; Sandmaier Brenda M; Maris Michael; Chauncey Thomas; Storb Rainer; Torok-Storb Beverly
Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):740-50.
-
2002: Georges George E; Maris Michael; Sandmaier Brenda M; Malone David G; Feinstein Lyle; Niederweiser Dietger; Shizuru Judith A; McSweeney Peter A; Chauncey Thomas R; Agura Edward; Little Marie-Trse; Sahebi Firoozeh; Hegenbart Ute; Pulsipher Michael A; Bruno Benedetto; Forman Stephen; Woolfrey Ann E; Radich Jerald P; Blume Karl G; Storb Rainer
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
International journal of hematology 2002;76 Suppl 1():184-9.
-
2002: Sandmaier Brenda M; Bethge Wolfgang A; Wilbur D Scott; Hamlin Donald K; Santos Erlinda B; Brechbiel Martin W; Fisher Darrell R; Storb Rainer
Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
Blood 2002;100(1):318-26.
-
2002: Appelbaum Frederick R; Sandmaier Brenda
Sensitivity of renal cell cancer to nonmyeloablative allogeneic hematopoietic cell transplantations: unusual or unusually important?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):1965-7.
-
2002: Mielcarek Marco; Sandmaier Brenda M; Maloney David G; Maris Michael; McSweeney Peter A; Woolfrey Ann; Chauncey Thomas; Feinstein Lyle; Niederwieser Dietger; Blume Karl G; Forman Stephen; Torok-Storb Beverly; Storb Rainer
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.
Journal of clinical immunology 2002;22(2):70-4.
-
2002: Junghanss Christian; Boeckh Michael; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Chauncey Thomas; McSweeney Peter A; Little Marie-Térèse; Corey Lawrence; Storb Rainer
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.
Blood 2002;99(6):1978-85.
-
2002: Mielcarek Marco; Zaucha J Maciej; Sandmaier Brenda; Maloney David; Butrynski James; Maris Michael; Feinstein Lyle; Torok-Storb Beverly; Storb Rainer
Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility.
British journal of haematology 2002;116(2):500-1.
-
2002: Warren E H; Tykodi S S; Murata M; Sandmaier B M; Storb R; Jaffee E; Childs R; Thompson J A; Greenberg P D; Riddell S R
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma.
Cytotherapy 2002;4(5):441.
-
2002: Maloney David G; Sandmaier Brenda M; Mackinnon Stephen; Shizuru Judith A
Non-myeloablative transplantation.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():392-421.
-
2002: Junghanss Christian; Marr Kieren A; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Chauncey Thomas; McSweeney Peter A; Storb Rainer
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):512-20.
-
2002: Jurado Manuel; Deeg H Joachim; Storer Barry; Anasetti Claudio; Anderson Jeanne E; Bryant Eileen; Chauncey Thomas; Doney Kris; Flowers Mary E D; Hansen John; Martin Paul J; Nash Richard A; Petersdorf Effie; Radich Jerry; Sale George; Sandmaier Brenda M; Storb Rainer; Wade James; Witherspoon Robert; Appelhaum Frederick R
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):161-9.
-
2001: Weissinger F; Sandmaier B M; Maloney D G; Bensinger W I; Gooley T; Storb R
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Blood 2001;98(13):3584-8.
-
2001: Georges G E; Storb R; Bruno B; Brodie S J; Thompson J D; Taranova A G; Zaucha J M; Little M T; Zellmer E; Moore P F; Gooley T; Sale G; Kiem H P; Sandmaier B M; Lyons R M; Nash R A
Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes.
Blood 2001;98(12):3447-55.
-
2001: Holmberg L A; Sandmaier B M
Theratope vaccine (STn-KLH).
Expert opinion on biological therapy 2001;1(5):881-91.
-
2001: Maris M; Woolfrey A; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D; Storb R
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century.
Frontiers in bioscience : a journal and virtual library 2001;6():G13-6.
-
2001: Maris M; Sandmaier B M; Maloney D G; McSweeney P A; Woolfrey A; Chauncey T; Shizuru J; Niederwieser D; Blume K G; Forman S; Storb R
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):231-4.
-
2001: Feinstein L; Sandmaier B; Maloney D; McSweeney P A; Maris M; Flowers C; Radich J; Little M T; Nash R A; Chauncey T; Woolfrey A; Georges G; Kiem H P; Zaucha J M; Blume K G; Shizuru J; Niederwieser D; Storb R
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Annals of the New York Academy of Sciences 2001;938():328-37; discussion 337-9.
-
2001: McSweeney P A; Niederwieser D; Shizuru J A; Sandmaier B M; Molina A J; Maloney D G; Chauncey T R; Gooley T A; Hegenbart U; Nash R A; Radich J; Wagner J L; Minor S; Appelbaum F R; Bensinger W I; Bryant E; Flowers M E; Georges G E; Grumet F C; Kiem H P; Torok-Storb B; Yu C; Blume K G; Storb R F
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
-
2000: Storb R; McSweeney P A; Sandmaier B M; Nash R A; Georges G; Maloney D G; Molina A; Chauncey T; Yu C; Zaucha J M; Blume K G; Shizuru J; Niederwieser D
Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century.
Transplantation proceedings 2000;32(7):2548-9.
-
2000: Holmberg L A; Oparin D V; Gooley T; Lilleby K; Bensinger W; Reddish M A; MacLean G D; Longenecker B M; Sandmaier B M
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.
Bone marrow transplantation 2000;25(12):1233-41.
-
2000: Sandmaier B M; McSweeney P; Yu C; Storb R
Nonmyeloablative transplants: preclinical and clinical results.
Seminars in oncology 2000;27(2 Suppl 5):78-81.
-
2000: Stucki A; Hayflick J S; Sandmaier B M
Antibody engagement of intercellular adhesion molecule 3 triggers apoptosis of normal and leukaemic myeloid marrow cells.
British journal of haematology 2000;108(1):157-66.
-
1999: Barsoukov A A; Moore P F; Storb R; Santos E B; Sandmaier B M
The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
Transplantation 1999;67(10):1329-35.
-
1999: Storb R; Yu C; Sandmaier B M; McSweeney P A; Georges G; Nash R A; Woolfrey A
Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting.
Annals of the New York Academy of Sciences 1999;872():372-5; discussion 375-6.
-
1999: Storb R; Yu C; Sandmaier B; McSweeney P; Georges G; Nash R; Woolfrey A
Mixed hematopoietic chimerism after hematopoietic stem cell allografts.
Transplantation proceedings 1999;31(1-2):677-8.
-
1999: Sandmaier B M; Oparin D V; Holmberg L A; Reddish M A; MacLean G D; Longenecker B M
Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(1):54-66.
-
1998: Stucki A; Leisenring W; Sandmaier B M; Sanders J; Anasetti C; Storb R
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Blood 1998;92(8):2742-9.
-
1998: Tan P H; Sandmaier B M; Stayton P S
Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Biophysical journal 1998;75(3):1473-82.
-
1998: Storb R; Yu C; Deeg H J; Georges G; Kiem H P; Mcsweeney P A; Nash R A; Sandmaier B M; Sullivan K M; Wagner J L; Walters M C
Current and future preparative regimens for bone marrow transplantation in thalassemia.
Annals of the New York Academy of Sciences 1998;850():276-87.
-
1998: Sandmaier B M; Storb R; Bennett K L; Appelbaum F R; Santos E B
Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model.
Blood 1998;91(9):3494-502.
-
1998: Yu C; Seidel K; Nash R A; Deeg H J; Sandmaier B M; Barsoukov A; Santos E; Storb R
Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts.
Blood 1998;91(7):2581-7.
-
1998: McSweeney P A; Rouleau K A; Wallace P M; Bruno B; Andrews R G; Krizanac-Bengez L; Sandmaier B M; Storb R; Wayner E; Nash R A
Characterization of monoclonal antibodies that recognize canine CD34.
Blood 1998;91(6):1977-86.
-
1998: Krizanac-Bengez L; Moore P F; Barsoukov A; Sandmaier B M
The expression and differentiation pattern of cell antigens and adhesion molecules on the nonadherent cell population in canine long-term marrow culture: a biphasic development of myeloid and lymphoid cells.
Tissue antigens 1998;51(2):141-55.
-
1996: Sandmaier B M; Storb R; Liu Y; Santos E B; Bryant E; Schuening F G; Deeg H J; Seidel K; Graham T
An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.
Transplant immunology 1996;4(4):271-4.
-
1996: McSweeney P A; Rouleau K A; Storb R; Bolles L; Wallace P M; Beauchamp M; Krizanac-Bengez L; Moore P; Sale G; Sandmaier B; de Revel T; Appelbaum F R; Nash R A
Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein.
Blood 1996;88(6):1992-2003.
-
1996: Sandmaier B M; Storb R; Santos E B; Krizanac-Bengez L; Lian T; McSweeney P A; Yu C; Schuening F G; Deeg H J; Graham T
Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors.
Blood 1996;87(8):3508-13.
-
1996: Rossbach H C; Krizanac-Bengez L; Santos E B; Gooley T A; Sandmaier B M
An antibody to CD44 enhances hematopoiesis in long-term marrow cultures.
Experimental hematology 1996;24(2):221-7.
-
1996: Bensinger W I; Clift R A; Anasetti C; Appelbaum F A; Demirer T; Rowley S; Sandmaier B M; Torok-Storb B; Storb R; Buckner C D
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor.
Stem cells (Dayton, Ohio) 1996;14(1):90-105.
-
1995: Storb R; Deeg H J; Raff R; Schuening F; Yu C; Sandmaier B M; Graham T
Prevention of graft-versus-host disease. Studies in a canine model.
Annals of the New York Academy of Sciences 1995;770():149-64.
-
1995: Yu C; Storb R; Mathey B; Deeg H J; Schuening F G; Graham T C; Seidel K; Burnett R; Wagner J L; Shulman H; Sandmaier B M
DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.
Blood 1995;86(11):4376-81.
-
1995: Tan P H; Sandmaier B M; Stayton P S
Characterization of an anti-CD44 single-chain FV antibody that stimulates natural killer cell activity and induces TNF alpha release.
Immunological investigations 1995;24(6):907-26.
-
1995: Tan P H; Liu Y; Santos E B; Sandmaier B M
Mechanisms of enhancement of natural killer activity by an antibody to CD44: increase in conjugate formation and release of tumor necrosis factor alpha.
Cellular immunology 1995;164(2):255-64.
-
1995: Mathey B; Yu C; Sandmaier B M; Deeg H J; Graham T; Schuening F G; Nash R A; Stor B
Failure of interleukin-1 and granulocyte-macrophage colony-stimulating factor to enhance allogeneic marrow engraftment and survival in irradiated dogs.
Blood 1995;86(2):833-4.
-
1995: Jakic-Razumovic J; Sale G E; Beauchamp M D; Storb R; Sandmaier B M
CD8+ activated T lymphocytes produce an in vitro skin graft-versus-host reaction in an organotypic skin culture model.
Transplantation 1995;59(1):69-78.
-
1994: Weaver C H; Petersen F B; Appelbaum F R; Bensinger W I; Press O; Martin P; Sandmaier B; Deeg H J; Hansen J A; Brunvand M
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2559-66.
-
1994: Weaver C H; Bensinger W I; Appelbaum F R; Lilleby K; Sandmaier B; Brunvand M; Rowley S; Petersdorf S; Rivkin S; Gooley T
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
Bone marrow transplantation 1994;14(5):813-9.
-
1994: Raff R F; Sandmaier B M; Graham T; Loughran T P; Pettinger M; Storb R
'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
Experimental hematology 1994;22(9):893-7.
-
1994: Jakic-Razumovic J; Storb R; Sandmaier B M; Sale G E
An organotypic skin culture model in dogs. A model for transplantation immunopathology in canine systems.
Transplantation 1994;57(2):285-7.
-
1993: Tan P H; Santos E B; Rossbach H C; Sandmaier B M
Enhancement of natural killer activity by an antibody to CD44.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(3):812-20.
-
1992: Appelbaum F R; Brown P A; Sandmaier B M; Storb R; Fisher D R; Shulman H M; Graham T C; Schuening F G; Deeg H J; Bianco J A
Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP.
Blood 1992;80(6):1608-13.
-
1991: Greinix H T; Ladiges W C; Graham T C; Maslan S; Raff R F; Sandmaier B M; Appelbaum F R; Schuening F G; Deeg H J; Storb R
Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.
Blood 1991;78(8):2131-8.
-
1991: Sandmaier B M; Schuening F G; Bianco J A; Rosenman S J; Bernstein I; Goehle S; Storb R; Appelbaum F R
Biochemical characterization of a unique canine myeloid antigen.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(2):125-30.
-
1990: Bianco J A; Brown P A; Durack L; Badger C; Bernstein I; Eary J; Durham J; Fisher D; Sandmaier B; Schuening F
Effects of propylthiouracil on the biodistribution of an iodine-131-labeled anti-myeloid antibody in normal dogs: dosimetry and clinical implications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(8):1384-9.
-
1990: Sandmaier B M; Storb R; Appelbaum F R; Gallatin W M
An antibody that facilitates hematopoietic engraftment recognizes CD44.
Blood 1990;76(3):630-5.
-
1990: Ladiges W C; Storb R; Raff R F; Appelbaum F R; Sandmaier B; Schuening F; Graham T
Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
Bone marrow transplantation 1990;5(1):43-6.
-
1989: Bianco J A; Sandmaier B; Brown P A; Badger C; Bernstein I; Eary J; Durack L; Schuening F; Storb R; Appelbaum F
Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization.
Experimental hematology 1989;17(9):929-34.
-
1989: Schuening F G; Storb R; Goehle S; Nash R; Graham T C; Appelbaum F R; Hackman R; Sandmaier B M; Urdal D L
Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1989;17(8):889-94.
-
1989: Appelbaum F R; Raff R F; Storb R; Deeg H J; Graham T C; Sandmaier B; Schuening F
Use of trimetrexate for the prevention of graft-versus-host disease.
Bone marrow transplantation 1989;4(4):421-4.
-
1989: Appelbaum F R; Brown P; Sandmaier B; Badger C; Schuening F; Graham T; Storb R
Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation.
Blood 1989;73(8):2202-8.
-
1988: Raff R F; Severns E; Storb R; Martin P; Graham T; Sandmaier B; Schuening F; Sale G; Appelbaum F R
L-leucyl-L-leucine methyl ester treatment of canine marrow and peripheral blood cells. Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftment.
Transplantation 1988;46(5):655-60.
-
1988: Storb R; Raff R F; Appelbaum F R; Schuening F W; Sandmaier B M; Graham T C; Thomas E D
What radiation dose for DLA-identical canine marrow grafts?
Blood 1988;72(4):1300-4.
-
1988: Storb R; Raff R F; Appelbaum F R; Schuening F W; Sandmaier B M; Graham T C
The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates.
Transplantation 1988;46(2):334-6.
-
1988: Appelbaum F R; Graham T; Sandmaier B; Schuening F; Storb R
Sensitivity of newly transplanted marrow to further irradiation.
Transplantation 1988;45(4):813-4.
-
1988: Storb R; Deeg H J; Applebaum F R; Schuening F; Sandmaier B; Raff R F; Graham T
Failure of anti-Ia monoclonal antibody to abrogate transfusion-induced sensitization and prevent marrow graft rejection in DLA-identical canine littermates.
Transplantation 1988;45(2):505-6.
-
1988: Storb R; Raff R F; Appelbaum F R; Schuening F; Sandmaier B; Shulman H; Deeg H J; Graham T
Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Transplantation 1988;45(1):236-9.
Sign-in to see more
